Winston-Salem, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Inmar Intelligence, the leading provider of data-driven healthcare technology solutions, today announced the appointment of Brian Nightengale as Executive Vice President & President, Healthcare Solutions. Brian brings a wealth of expertise spanning the pharmaceutical supply chain, clinical care, and strategic commercialization, that will serve as a critical addition to Inmar Intelligence's healthcare leadership team.  Brian’s extensive background will play a pivotal role in advancing Inmar Intelligence's mission to drive safety, create operational efficiencies, and demonstrate value to stakeholders throughout the healthcare supply chain.

Winston-Salem，2023年10月10日（GLOBE NEWSWIRE）-数据驱动医疗技术解决方案的领先提供商Inmar Intelligence今天宣布任命Brian Nightengale担任医疗保健解决方案的执行副总裁兼总裁。Brian在制药供应链，临床护理和战略商业化方面拥有丰富的专业知识，这将成为Inmar Intelligence医疗保健领导团队的重要补充。布莱恩的广泛背景将在推进Inmar情报的使命中发挥关键作用，推动安全，提高运营效率，并向整个医疗保健供应链中的利益相关者展示价值。

With a foundation as a pharmacist, Brian has worked across multiple healthcare settings, including chain and independent retail, long-term care, health systems, and nuclear pharmacies. He then dedicated two decades to collaborating closely with pharmaceutical manufacturers, devising data-driven commercialization strategies for their groundbreaking products.

布莱恩作为药剂师的基础，曾在多个医疗机构工作，包括连锁和独立零售，长期护理，卫生系统和核药店。然后，他致力于二十年与制药商密切合作，为其开创性产品制定数据驱动的商业化战略。

In his most recent role, he spent seven years in wholesale distribution, supporting pharmacies with a comprehensive suite of products and financial solutions to enhance their operational efficiency and growth. 'I am honored to join Inmar Intelligence and I am very excited to work with the team to invent new ways to create even more value for our customers,” said Brian Nightengale.

在他最近的角色中，他花了七年的时间进行批发分销，为药房提供全面的产品和财务解决方案，以提高其运营效率和增长Brian Nightengale说，我很荣幸加入Inmar Intelligence，我非常高兴与团队合作，发明新方法为客户创造更多价值。

“With a unique background in healthcare and a deep understanding of the pharmaceutical supply chain, I look forward to helping Inmar continue to accelerate its growth and deepen its commitment to improving patient outcomes.' Spencer Baird, CEO of Inmar Intelligence, shared his enthusiasm for the new addition, saying, 'Brian's extensive background is a va.

“凭借独特的医疗保健背景和对药品供应链的深刻理解，我期待帮助Inmar继续加速其发展并加深其改善患者预后的承诺。”Inmar Intelligence首席执行官Spencer Baird分享了他对新增加的热情，说：“布莱恩的广泛背景是va。